ANHYDROUS DOCETAXEL

DRUG2 trials

Sponsors

Fondation Franc.Cancerologie Digestive, The University Of Birmingham

Conditions

Locally advanced or metastatic oesogastric adenocarcinomaRecurrent and Primary Refractory Ewing Sarcoma

Phase 2

PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

CompletedCTIS2024-515221-29-00

Fondation Franc.Cancerologie DigestiveLocally advanced or metastatic oesogastric adenocarcinoma

Start: 2016-12-19End: 2025-02-27Target: 507Updated: 2024-07-04

rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma

RecruitingCTIS2024-516078-31-00

The University Of BirminghamRecurrent and Primary Refractory Ewing Sarcoma

Start: 2015-05-05Target: 436Updated: 2024-12-04